Sa1824 Identification of Potential Biomarkers of Netazepide (YF476) Treatment of Type I Gastric Neuroendocrine Tumours

Andrew R. Moore; Bryony N. Parsons; Malcolm J. Boyce; Lucille Rainbow; Yongxiang Fang; Andrea Varro; Neil Hall; D. M. Pritchard

doi:10.1016/S0016-5085(15)31140-9

Sa1824 Identification of Potential Biomarkers of Netazepide (YF476) Treatment of Type I Gastric Neuroendocrine Tumours

Andrew R. Moore, Bryony N. Parsons, Malcolm J. Boyce, Lucille Rainbow, Yongxiang Fang, Andrea Varro, Neil Hall, D. M. Pritchard

School of Biological Sciences

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Pages (from-to)	S-342
Number of pages	1
Journal	Gastroenterology
Volume	148
Issue number	4
Early online date	26 Apr 2015
DOIs	https://doi.org/10.1016/S0016-5085(15)31140-9
Publication status	Published - Apr 2015

Access to Document

10.1016/S0016-5085(15)31140-9

https://linkinghub.elsevier.com/retrieve/pii/S0016508515311409

Neil Hall
- Neil.Halluea.acuk
- School of Biological Sciences - Professor in Genomics & Director of Earlham Institute
Person: Academic, Teaching and Research

Cite this

@article{a67b25e2a97b44f89b225be160c5f288,

title = "Sa1824 Identification of Potential Biomarkers of Netazepide (YF476) Treatment of Type I Gastric Neuroendocrine Tumours",

author = "Moore, {Andrew R.} and Parsons, {Bryony N.} and Boyce, {Malcolm J.} and Lucille Rainbow and Yongxiang Fang and Andrea Varro and Neil Hall and Pritchard, {D. M.}",

year = "2015",

month = apr,

doi = "10.1016/S0016-5085(15)31140-9",

language = "English",

volume = "148",

pages = "S--342",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Sa1824 Identification of Potential Biomarkers of Netazepide (YF476) Treatment of Type I Gastric Neuroendocrine Tumours

AU - Moore, Andrew R.

AU - Parsons, Bryony N.

AU - Boyce, Malcolm J.

AU - Rainbow, Lucille

AU - Fang, Yongxiang

AU - Varro, Andrea

AU - Hall, Neil

AU - Pritchard, D. M.

PY - 2015/4

Y1 - 2015/4

U2 - 10.1016/S0016-5085(15)31140-9

DO - 10.1016/S0016-5085(15)31140-9

M3 - Abstract

SN - 0016-5085

VL - 148

SP - S-342

JO - Gastroenterology

JF - Gastroenterology

IS - 4

ER -

Sa1824 Identification of Potential Biomarkers of Netazepide (YF476) Treatment of Type I Gastric Neuroendocrine Tumours

Access to Document

Profiles

Neil Hall

Cite this